集中的な減量介入に対する不良反応の初期と進化のプロファイル: RESOLVE 研究
Mélina Bailly1, Laurie Isacco1, Frédéric Dutheil2
1Laboratory of the Metabolic Adaptations to Exercise Under Physiological and Pathological Conditions (AME2P), Research Center for Human Nutrition Auvergne (CRNH), Clermont Auvergne University, Clermont-Ferrand, France.
The Journal of sports medicine and physical fitness
|September 5, 2025
まとめ
介入後に体重が戻った人を特定することは 極めて重要です 予期せぬ反応を示した患者には,より健康的なベースラインプロフィールがあり,長期的に体重管理の成功に影響を与える有害なホルモン変化がある可能性があります.
科学分野:
- 肥満に関する研究
- メタボリック・ヘルス
- 行動科学
背景:
- パーソナライズされた治療戦略には 減量介入に悪影響を及ぼす人物の 特定が不可欠です
- 長期的な体重増加パターンを理解することは 公衆衛生にとって極めて重要です
研究 の 目的:
- 減量介入に対する不良反応の予測要因を特定する.
- 体重回復パターンによって分類された参加者の長期的な進化を分析する.
主な方法:
- 3週間の介入 (食事と身体活動) を続き,1年間のモニタリングを100人の肥満患者で実施した.
- 参加者は"回復者" (グループA),"適度な回復者" (グループB),そして"体重再減量者" (グループC) に分けられました.
- 体組成,食物摂取量,炎症および代謝マーカー,飽和ホルモン (グリリン,PYY) の評価
主要な成果:
- グループA (再利用者) は,ベースラインより低いエネルギー摂取量と,グループBとグループCよりも健康的な初期代謝プロファイルを示した.
- フォローアップの間,グループAでは従順度 (ダイエット + 運動) が低いことが観察されました.
- 体重減少介入に対するグリリンとペプチドYY (PYY) の反応は,他のグループと比較してAグループでは鈍化した.
結論:
- 体重減少に対する不良反応は,出血時により不健康な代謝プロファイルを示します.
- フォローアップ中に飽和感を調節するホルモン (グリリン,PYY) の不利な変化が不良反応者を特徴づける.
- 体重減少への不良反応を予測する要因には,基礎代謝健康とホルモン反応パターンが含まれます.
関連する概念動画
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
Obesity
609
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
609
Factors Affecting Drug Response: Overview
2.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
407
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
407


